Neoplasms - Mortality
Research News and Information

Saturday, November 21, 2009

Model-based projections for deriving up-to-date cancer survival estimates: an international evaluation.

29 Nov 2009 Model-based projections were shown to be useful for deriving most up-to-date population-based cancer survival estimates. However, the performance of these projections, which can be derived by various approaches, has only been evaluated in very few ... Read more...

Serum cholesterol levels in relation to the incidence of cancer: the JPHC study cohorts.

29 Nov 2009 An inverse association between serum total cholesterol and cancer mortality cast a controversy for cause or result of low cholesterol on cancer risk. Therefore, we examined a total of 33,368 Japanese men and women aged 40-69 years, who were free of ... Read more...

Quality of life in a prospective cohort of elderly women with and without cancer.

13 Sep 2009 BACKGROUND: Quality of life (QOL) is an important issue for cancer survivors; few studies are able to consider elderly populations, address long-term survival (>or=5 years), examine different cancers, or include a valid noncancer comparison group. ... Read more...

Latest indexed articles for 'Neoplasms - Mortality'

These are the very latest articles for this heading:

• Model-based projections for deriving up-to-date cancer survival estimates: an international evaluation. 29 Nov 2009
• Serum cholesterol levels in relation to the incidence of cancer: the JPHC study cohorts. 29 Nov 2009
• Current concerns and challenges regarding tailored anti-angiogenic therapy in cancer. 29 Sep 2009
• Pharmacology, pharmacogenetics, and pharmacoepidemiology: three ps of individualized therapy. 29 Sep 2009
• Questions remain over validity of EUROCARE data. 17 Sep 2009
• Proceedings of the 4th Biennial Cancer Survivorship Research Conference: Mapping the New Challenges, Atlanta, Georgia, USA. 13 Sep 2009
• Quality of life in a prospective cohort of elderly women with and without cancer. 13 Sep 2009
• Drugs are scarce as mix of programs aims to ease access. 13 Sep 2009
• Cancer, clots and consensus: new understanding of an old problem. 12 Sep 2009
• Prevention of thrombosis in ambulatory patients with cancer. 12 Sep 2009
• A shot at cancer. 12 Sep 2009
• Meat intake and mortality: evidence for harm, no effect, or benefit? 12 Sep 2009
• Impact of venous thromboembolism and anticoagulation on cancer and cancer survival. 6 Sep 2009
• Role of tissue factor in cancer. 6 Sep 2009
• Genetic link between cancer and thrombosis. 6 Sep 2009
• Prevention of venous thromboembolism in the cancer surgical patient. 6 Sep 2009
• Diagnosis and initial treatment of venous thromboembolism in patients with cancer. 6 Sep 2009
• New antithrombotic drugs: potential for use in oncology. 6 Sep 2009
• A prospective study of bone lead concentration and death from all causes, cardiovascular diseases, and cancer in the Department of Veterans Affairs Normative Aging Study. 6 Sep 2009
• An internet tool for creation of cancer survivorship care plans for survivors and health care providers: design, implementation, use and user satisfaction. 2 Sep 2009

See a longer list of these articles.

Technical information about 'Neoplasms'

Definition: New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms.

Descriptor UI: D009369

Alternative terms: Neoplasms; Neoplasm; Tumors; Tumor; Benign Neoplasms; Neoplasms, Benign; Benign Neoplasm; Neoplasm, Benign; Cancer; Cancers;

Related Mesh Headings: Antibodies, Neoplasm; Antigens, Neoplasm; Antineoplastic Agents; Carcinogens; DNA, Neoplasm; Oncogenic Viruses; Precancerous Conditions; RNA, Neoplasm; Pleural Effusion, Malignant; Genes, Tumor Suppressor; Anticarcinogenic Agents;

Allowable Qualifiers: blood; blood supply; cerebrospinal fluid; chemically induced; classification; complications; congenital; diagnosis; diet therapy; drug therapy; economics; embryology; enzymology; ethnology; etiology; genetics; history; immunology; metabolism; microbiology; mortality; nursing; epidemiology; parasitology; pathology; physiopathology; prevention & control; psychology; radiography; radionuclide imaging; radiotherapy; rehabilitation; secretion; surgery; therapy; ultrastructure; urine; veterinary; ultrasonography; chemistry; virology;

Tree Number: C04;

Online Note: pre-explosion = NEOPLASMS (PX)

History Note: /diagnosis was NEOPLASM DIAGNOSIS 1964-65; /etiology was NEOPLASM ETIOLOGY 1964-65; /immunology was NEOPLASM IMMUNOLOGY 1964-65; /radiotherapy was NEOPLASM RADIOTHERAPY 1964-65; /therapy was NEOPLASM THERAPY 1964-65; NEOPLASM STATISTICS was heading 1964-65; CARCINOGENESIS was heading 1977

Technical Notes: avoid: too general; prefer specifics; policy: Manual section 24; /chem ind permitted but consider also CARCINOGENS; /class: consider also NEOPLASM STAGING (see note there) but "grading" = /pathol; /etiol: consider also ONCOGENIC VIRUSES; /vet: Manual 24.6+ or TN 136; TN 135: MeSH terms for neoplasms classed by tissue; /drug ther: consider also ANTINEOPLASTIC AGENTS & its specifics; /genet: consider also GENES, TUMOR SUPPRESSOR /immunol: consider also TUMOR ESCAPE; consider also ANTIGENS, NEOPLASM & ANTIBODIES, NEOPLASM; /microbiol: consider also ONCOGENIC VIRUSES; /nurs = the patient, ONCOLOGIC NURSING = the oncologic specialty; /prev: consider also ANTICARCINOGENIC AGENTS; /radiother = the patient, RADIATION ONCOLOGY = the specialty; consider also BRACHYTHERAPY; /second = NEOPLASM METASTASIS but do not confuse with NEOPLASMS, SECOND PRIMARY; familial: consider also NEOPLASTIC SYNDROMES, HEREDITARY; metastatic cancer of unknown origin: index under NEOPLASM METASTASIS; Tumor Key: TN Suppl